Tagrisso
The Top Pharma List rankings are compiled from GlobalData’s pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. Listed below are the charts and positions for Tagrisso in this year’s pharmaceutical sales data alongside recent articles on PMLiVE featuring Tagrisso.
22
Global Revenue Ranking
25
2030 Global forecast Ranking
Recent articles on PMLiVE featuring Tagrisso
Approximately 6,600 people are diagnosed with liver cancer every year in the UK
An estimated 2.4 million people globally are diagnosed with lung cancer each year
The regimen was approved by the MHRA earlier this month to treat EGFR-mutated NSCLC
Approximately 47,000 people are diagnosed with lung cancer every year in the UK
More than 49,000 people are diagnosed with lung cancer in the UK each year
Alterations in EGFR are among the most common driver mutations in NSCLC patients
More than 450,000 people are diagnosed with lung cancer each year in Europe
More than 200,000 people are diagnosed with lung cancer in the US every year
Alterations in EGFR are among the most common driver mutations in lung cancer patients
The chemotherapy-free regimen was approved in the US last month for advanced lung cancer patients
Approximately 484,306 cases of lung cancer were diagnosed in Europe in 2022
Non-small cell lung cancer accounts for up to 85% of all lung cancer cases
Data provided by GlobalData
GlobalData provides trusted intelligence on the world’s largest industries including Pharmaceutical and Medical Devices. With over 2,000 in-house experts, our data-driven, technology-powered approach delivers gold-standard insights to help businesses navigate complex markets and predict future trends.
Our integrated platform empowers 4,000 of the world’s largest companies—including over 70% of FTSE 100 and 60% of Fortune 100 firms—to make timely, informed decisions through unique data, expert analysis, and innovative consulting solutions.
To find out more about how our research and insights can help you, please visit https://www.globaldata.com/who-we-are/why-globaldata/
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE’s Top Pharma List – Methodology